The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Polymyxin B for Injection Market Research Report 2025
Synopsis
The global Polymyxin B for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Polymyxin B for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Polymyxin B for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Polymyxin B for Injection include Xellia, Fresenius Kabi, Shanghai Pharmaceuticals, Eugia, Gland Pharma, Soigner Pharma, Incepta Pharmaceuticals and Taj Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Polymyxin B for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymyxin B for Injection.
Report Scope
The Polymyxin B for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymyxin B for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymyxin B for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Xellia
Fresenius Kabi
Shanghai Pharmaceuticals
Eugia
Gland Pharma
Soigner Pharma
Incepta Pharmaceuticals
Taj Pharmaceuticals
Segment by Type
50,000 Units
Others
Segment by Application
Hospital
Clinics
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymyxin B for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polymyxin B for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Polymyxin B for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Polymyxin B for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Polymyxin B for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Polymyxin B for Injection include Xellia, Fresenius Kabi, Shanghai Pharmaceuticals, Eugia, Gland Pharma, Soigner Pharma, Incepta Pharmaceuticals and Taj Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Polymyxin B for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymyxin B for Injection.
Report Scope
The Polymyxin B for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymyxin B for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymyxin B for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Xellia
Fresenius Kabi
Shanghai Pharmaceuticals
Eugia
Gland Pharma
Soigner Pharma
Incepta Pharmaceuticals
Taj Pharmaceuticals
Segment by Type
50,000 Units
Others
Segment by Application
Hospital
Clinics
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymyxin B for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polymyxin B for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Polymyxin B for Injection Market Overview
1.1 Product Overview and Scope of Polymyxin B for Injection
1.2 Polymyxin B for Injection Segment by Type
1.2.1 Global Polymyxin B for Injection Market Value Comparison by Type (2024-2030)
1.2.2 50,000 Units
1.2.3 Others
1.3 Polymyxin B for Injection Segment by Application
1.3.1 Global Polymyxin B for Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Polymyxin B for Injection Market Size Estimates and Forecasts
1.4.1 Global Polymyxin B for Injection Revenue 2019-2030
1.4.2 Global Polymyxin B for Injection Sales 2019-2030
1.4.3 Global Polymyxin B for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Polymyxin B for Injection Market Competition by Manufacturers
2.1 Global Polymyxin B for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Polymyxin B for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Polymyxin B for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Polymyxin B for Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polymyxin B for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polymyxin B for Injection, Product Type & Application
2.7 Polymyxin B for Injection Market Competitive Situation and Trends
2.7.1 Polymyxin B for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Polymyxin B for Injection Players Market Share by Revenue
2.7.3 Global Polymyxin B for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polymyxin B for Injection Retrospective Market Scenario by Region
3.1 Global Polymyxin B for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Polymyxin B for Injection Global Polymyxin B for Injection Sales by Region: 2019-2030
3.2.1 Global Polymyxin B for Injection Sales by Region: 2019-2024
3.2.2 Global Polymyxin B for Injection Sales by Region: 2025-2030
3.3 Global Polymyxin B for Injection Global Polymyxin B for Injection Revenue by Region: 2019-2030
3.3.1 Global Polymyxin B for Injection Revenue by Region: 2019-2024
3.3.2 Global Polymyxin B for Injection Revenue by Region: 2025-2030
3.4 North America Polymyxin B for Injection Market Facts & Figures by Country
3.4.1 North America Polymyxin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Polymyxin B for Injection Sales by Country (2019-2030)
3.4.3 North America Polymyxin B for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Polymyxin B for Injection Market Facts & Figures by Country
3.5.1 Europe Polymyxin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Polymyxin B for Injection Sales by Country (2019-2030)
3.5.3 Europe Polymyxin B for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Polymyxin B for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Polymyxin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Polymyxin B for Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Polymyxin B for Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Polymyxin B for Injection Market Facts & Figures by Country
3.7.1 Latin America Polymyxin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Polymyxin B for Injection Sales by Country (2019-2030)
3.7.3 Latin America Polymyxin B for Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Polymyxin B for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Polymyxin B for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Polymyxin B for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Polymyxin B for Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polymyxin B for Injection Sales by Type (2019-2030)
4.1.1 Global Polymyxin B for Injection Sales by Type (2019-2024)
4.1.2 Global Polymyxin B for Injection Sales by Type (2025-2030)
4.1.3 Global Polymyxin B for Injection Sales Market Share by Type (2019-2030)
4.2 Global Polymyxin B for Injection Revenue by Type (2019-2030)
4.2.1 Global Polymyxin B for Injection Revenue by Type (2019-2024)
4.2.2 Global Polymyxin B for Injection Revenue by Type (2025-2030)
4.2.3 Global Polymyxin B for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Polymyxin B for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Polymyxin B for Injection Sales by Application (2019-2030)
5.1.1 Global Polymyxin B for Injection Sales by Application (2019-2024)
5.1.2 Global Polymyxin B for Injection Sales by Application (2025-2030)
5.1.3 Global Polymyxin B for Injection Sales Market Share by Application (2019-2030)
5.2 Global Polymyxin B for Injection Revenue by Application (2019-2030)
5.2.1 Global Polymyxin B for Injection Revenue by Application (2019-2024)
5.2.2 Global Polymyxin B for Injection Revenue by Application (2025-2030)
5.2.3 Global Polymyxin B for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Polymyxin B for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Xellia
6.1.1 Xellia Corporation Information
6.1.2 Xellia Description and Business Overview
6.1.3 Xellia Polymyxin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Xellia Polymyxin B for Injection Product Portfolio
6.1.5 Xellia Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Corporation Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Polymyxin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius Kabi Polymyxin B for Injection Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Shanghai Pharmaceuticals
6.3.1 Shanghai Pharmaceuticals Corporation Information
6.3.2 Shanghai Pharmaceuticals Description and Business Overview
6.3.3 Shanghai Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shanghai Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.3.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.4 Eugia
6.4.1 Eugia Corporation Information
6.4.2 Eugia Description and Business Overview
6.4.3 Eugia Polymyxin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eugia Polymyxin B for Injection Product Portfolio
6.4.5 Eugia Recent Developments/Updates
6.5 Gland Pharma
6.5.1 Gland Pharma Corporation Information
6.5.2 Gland Pharma Description and Business Overview
6.5.3 Gland Pharma Polymyxin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gland Pharma Polymyxin B for Injection Product Portfolio
6.5.5 Gland Pharma Recent Developments/Updates
6.6 Soigner Pharma
6.6.1 Soigner Pharma Corporation Information
6.6.2 Soigner Pharma Description and Business Overview
6.6.3 Soigner Pharma Polymyxin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Soigner Pharma Polymyxin B for Injection Product Portfolio
6.6.5 Soigner Pharma Recent Developments/Updates
6.7 Incepta Pharmaceuticals
6.6.1 Incepta Pharmaceuticals Corporation Information
6.6.2 Incepta Pharmaceuticals Description and Business Overview
6.6.3 Incepta Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Incepta Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.7.5 Incepta Pharmaceuticals Recent Developments/Updates
6.8 Taj Pharmaceuticals
6.8.1 Taj Pharmaceuticals Corporation Information
6.8.2 Taj Pharmaceuticals Description and Business Overview
6.8.3 Taj Pharmaceuticals Polymyxin B for Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taj Pharmaceuticals Polymyxin B for Injection Product Portfolio
6.8.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polymyxin B for Injection Industry Chain Analysis
7.2 Polymyxin B for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polymyxin B for Injection Production Mode & Process
7.4 Polymyxin B for Injection Sales and Marketing
7.4.1 Polymyxin B for Injection Sales Channels
7.4.2 Polymyxin B for Injection Distributors
7.5 Polymyxin B for Injection Customers
8 Polymyxin B for Injection Market Dynamics
8.1 Polymyxin B for Injection Industry Trends
8.2 Polymyxin B for Injection Market Drivers
8.3 Polymyxin B for Injection Market Challenges
8.4 Polymyxin B for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Polymyxin B for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Polymyxin B for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Polymyxin B for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Polymyxin B for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Polymyxin B for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Polymyxin B for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Polymyxin B for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Polymyxin B for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Polymyxin B for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Polymyxin B for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Polymyxin B for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Polymyxin B for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polymyxin B for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymyxin B for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Polymyxin B for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Polymyxin B for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Polymyxin B for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Polymyxin B for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Polymyxin B for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Polymyxin B for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Polymyxin B for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Polymyxin B for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Polymyxin B for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Polymyxin B for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Polymyxin B for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Polymyxin B for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Polymyxin B for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Polymyxin B for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Polymyxin B for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Polymyxin B for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Polymyxin B for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Polymyxin B for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Polymyxin B for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Polymyxin B for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Polymyxin B for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Polymyxin B for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Polymyxin B for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Polymyxin B for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Polymyxin B for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Polymyxin B for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Polymyxin B for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Polymyxin B for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Polymyxin B for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Polymyxin B for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Polymyxin B for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Polymyxin B for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Polymyxin B for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Polymyxin B for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Polymyxin B for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Polymyxin B for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Polymyxin B for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Polymyxin B for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Polymyxin B for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Polymyxin B for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Polymyxin B for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Polymyxin B for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Polymyxin B for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Polymyxin B for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Polymyxin B for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Polymyxin B for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Polymyxin B for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Polymyxin B for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Polymyxin B for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Polymyxin B for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Polymyxin B for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Polymyxin B for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Polymyxin B for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Polymyxin B for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Xellia Corporation Information
Table 71. Xellia Description and Business Overview
Table 72. Xellia Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Xellia Polymyxin B for Injection Product
Table 74. Xellia Recent Developments/Updates
Table 75. Fresenius Kabi Corporation Information
Table 76. Fresenius Kabi Description and Business Overview
Table 77. Fresenius Kabi Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Fresenius Kabi Polymyxin B for Injection Product
Table 79. Fresenius Kabi Recent Developments/Updates
Table 80. Shanghai Pharmaceuticals Corporation Information
Table 81. Shanghai Pharmaceuticals Description and Business Overview
Table 82. Shanghai Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Shanghai Pharmaceuticals Polymyxin B for Injection Product
Table 84. Shanghai Pharmaceuticals Recent Developments/Updates
Table 85. Eugia Corporation Information
Table 86. Eugia Description and Business Overview
Table 87. Eugia Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Eugia Polymyxin B for Injection Product
Table 89. Eugia Recent Developments/Updates
Table 90. Gland Pharma Corporation Information
Table 91. Gland Pharma Description and Business Overview
Table 92. Gland Pharma Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Gland Pharma Polymyxin B for Injection Product
Table 94. Gland Pharma Recent Developments/Updates
Table 95. Soigner Pharma Corporation Information
Table 96. Soigner Pharma Description and Business Overview
Table 97. Soigner Pharma Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Soigner Pharma Polymyxin B for Injection Product
Table 99. Soigner Pharma Recent Developments/Updates
Table 100. Incepta Pharmaceuticals Corporation Information
Table 101. Incepta Pharmaceuticals Description and Business Overview
Table 102. Incepta Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Incepta Pharmaceuticals Polymyxin B for Injection Product
Table 104. Incepta Pharmaceuticals Recent Developments/Updates
Table 105. Taj Pharmaceuticals Corporation Information
Table 106. Taj Pharmaceuticals Description and Business Overview
Table 107. Taj Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Taj Pharmaceuticals Polymyxin B for Injection Product
Table 109. Taj Pharmaceuticals Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Polymyxin B for Injection Distributors List
Table 113. Polymyxin B for Injection Customers List
Table 114. Polymyxin B for Injection Market Trends
Table 115. Polymyxin B for Injection Market Drivers
Table 116. Polymyxin B for Injection Market Challenges
Table 117. Polymyxin B for Injection Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Polymyxin B for Injection
Figure 2. Global Polymyxin B for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Polymyxin B for Injection Market Share by Type in 2023 & 2030
Figure 4. 50,000 Units Product Picture
Figure 5. Others Product Picture
Figure 6. Global Polymyxin B for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Polymyxin B for Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Polymyxin B for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Polymyxin B for Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Polymyxin B for Injection Sales (2019-2030) & (K Units)
Figure 14. Global Polymyxin B for Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Polymyxin B for Injection Report Years Considered
Figure 16. Polymyxin B for Injection Sales Share by Manufacturers in 2023
Figure 17. Global Polymyxin B for Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Polymyxin B for Injection Players: Market Share by Revenue in 2023
Figure 19. Polymyxin B for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Polymyxin B for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Polymyxin B for Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Polymyxin B for Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Polymyxin B for Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Polymyxin B for Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Polymyxin B for Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Polymyxin B for Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Polymyxin B for Injection Sales Market Share by Country (2019-2030)
Figure 42. Latin America Polymyxin B for Injection Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Polymyxin B for Injection Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Polymyxin B for Injection Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Polymyxin B for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Polymyxin B for Injection by Type (2019-2030)
Figure 53. Global Revenue Market Share of Polymyxin B for Injection by Type (2019-2030)
Figure 54. Global Polymyxin B for Injection Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Polymyxin B for Injection by Application (2019-2030)
Figure 56. Global Revenue Market Share of Polymyxin B for Injection by Application (2019-2030)
Figure 57. Global Polymyxin B for Injection Price (US$/Unit) by Application (2019-2030)
Figure 58. Polymyxin B for Injection Value Chain
Figure 59. Polymyxin B for Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
